Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-24

Clinical Trial Update: Expanded Access to Fosmanogepix for Patients With Serious or Life-threatening Invasive Fungal Infections

View source ↗

Summary

Expanded access (compassionate use) for fosmanogepix is being offered to patients with serious or life-threatening invasive fungal infections, sponsored by Basi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • fosmanogepix (fosmanogepix)

Snippet

Sponsor: Basilea Pharmaceutica | Conditions: Invasive Fungal Infections | Status: AVAILABLE